Fréderic Vellieux

6PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMajor global burdens of diseaseImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 05, 2025
Interaction of Selected Anthracycline and Tetracycline Chemotherapeutics with Poly(I:C) Molecules.

Markéta Skaličková, Nikita Abramenko, Tatsiana Charnavets

|Aug 13, 2024
Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy.

Zdeněk Kejík, Jan Hajduch, Nikita Abramenko

|Sep 23, 2022
Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators.

Veronika Antonyová, Ameneh Tatar, Tereza Brogyányi

|Jan 21, 2022
Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways.

Lubomír Minařík, Kristýna Pimková, Juraj Kokavec

|Jul 02, 2021
Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences.

Nikita Abramenko, Fréderic Vellieux, Petra Tesařová

|Oct 29, 2020
Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19.

Jan Brábek, Milan Jakubek, Fréderic Vellieux

Pageof 1

Frequent Collaborators

5 joint publications

Milan Jakubek

2 joint publications

Lukáš Lacina

2 joint publications

Daniel Rösel

2 joint publications

Karel Smetana